Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-26.5%
5Y CAGR-16.9%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-26.5%/yr
vs +0.5%/yr prior
5Y CAGR
-16.9%/yr
Recent deceleration
Acceleration
-27.1pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.85 | -8.0% |
| 2024 | 2.01 | -50.1% |
| 2023 | 4.02 | -13.8% |
| 2022 | 4.66 | +1.9% |
| 2021 | 4.57 | -1.9% |
| 2020 | 4.66 | -3.8% |
| 2019 | 4.85 | +6.3% |
| 2018 | 4.56 | -38.8% |
| 2017 | 7.46 | -7.8% |
| 2016 | 8.09 | - |